9.46
price down icon0.94%   -0.09
 
loading
Precedente Chiudi:
$9.55
Aprire:
$9.59
Volume 24 ore:
5.00M
Relative Volume:
0.83
Capitalizzazione di mercato:
$1.54B
Reddito:
$1.08B
Utile/perdita netta:
$422.82M
Rapporto P/E:
4.1491
EPS:
2.28
Flusso di cassa netto:
$-637.33M
1 W Prestazione:
+10.64%
1M Prestazione:
+27.84%
6M Prestazione:
+68.93%
1 anno Prestazione:
-34.40%
Intervallo 1D:
Value
$9.24
$9.75
Intervallo di 1 settimana:
Value
$8.32
$9.75
Portata 52W:
Value
$5.01
$14.70

Novavax Inc Stock (NVAX) Company Profile

Name
Nome
Novavax Inc
Name
Telefono
240-268-2000
Name
Indirizzo
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Name
Dipendente
1,992
Name
Cinguettio
@novavax
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
NVAX's Discussions on Twitter

Confronta NVAX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NVAX
Novavax Inc
9.46 1.55B 1.08B 422.82M -637.33M 2.28
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
403.30 104.83B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
600.00 63.59B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.35 60.43B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
800.00 48.45B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
343.87 37.91B 4.56B -176.77M 225.30M -1.7177

Novavax Inc Stock (NVAX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-08-28 Ripresa H.C. Wainwright Buy
2025-08-20 Downgrade BofA Securities Neutral → Underperform
2025-06-17 Iniziato Citigroup Sell
2025-02-28 Iniziato BTIG Research Buy
2024-07-30 Downgrade JP Morgan Neutral → Underweight
2024-05-10 Aggiornamento BofA Securities Underperform → Neutral
2024-05-10 Aggiornamento JP Morgan Underweight → Neutral
2023-08-09 Aggiornamento B. Riley Securities Neutral → Buy
2023-04-20 Downgrade TD Cowen Outperform → Market Perform
2023-03-01 Downgrade B. Riley Securities Buy → Neutral
2023-01-09 Reiterato B. Riley Securities Buy
2022-12-30 Reiterato H.C. Wainwright Buy
2022-12-02 Iniziato Jefferies Hold
2022-09-22 Downgrade JP Morgan Neutral → Underweight
2022-05-20 Iniziato BofA Securities Underperform
2022-02-23 Reiterato B. Riley Securities Buy
2022-02-22 Ripresa Jefferies Buy
2022-01-21 Iniziato Cowen Outperform
2021-05-12 Downgrade JP Morgan Overweight → Neutral
2020-12-14 Iniziato Jefferies Buy
2020-08-06 Reiterato H.C. Wainwright Buy
2020-08-05 Aggiornamento JP Morgan Neutral → Overweight
2020-08-05 Downgrade Ladenburg Thalmann Neutral → Sell
2020-07-16 Reiterato H.C. Wainwright Buy
2020-07-08 Downgrade Ladenburg Thalmann Buy → Neutral
2020-06-29 Reiterato B. Riley FBR Buy
2020-06-29 Reiterato H.C. Wainwright Buy
2020-06-05 Aggiornamento JP Morgan Underweight → Neutral
2020-05-28 Reiterato B. Riley FBR Buy
2020-05-12 Reiterato H.C. Wainwright Buy
2020-04-30 Reiterato H.C. Wainwright Buy
2019-11-27 Ripresa B. Riley FBR Buy
2019-08-14 Reiterato H.C. Wainwright Buy
2019-02-28 Downgrade Piper Jaffray Overweight → Underweight
2018-12-18 Iniziato Ladenburg Thalmann Buy
2018-12-11 Iniziato Oppenheimer Outperform
2018-11-26 Aggiornamento Piper Jaffray Neutral → Overweight
2018-09-21 Aggiornamento JP Morgan Underweight → Overweight
2018-03-29 Aggiornamento Seaport Global Securities Neutral → Buy
Mostra tutto

Novavax Inc Borsa (NVAX) Ultime notizie

pulisher
Oct 03, 2025

A Fresh Look at Novavax (NVAX) Valuation After Recent Share Price Rebound - Yahoo Finance

Oct 03, 2025
pulisher
Oct 03, 2025

Smart tools for monitoring Novavax Inc.’s price actionRate Hike & Fast Momentum Stock Entry Tips - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Analyzing recovery setups for Novavax Inc. investorsJuly 2025 Update & Real-Time Chart Pattern Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is Novavax Inc. (NVV1) stock a buy on weaknessCEO Change & Momentum Based Trading Signals - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is Novavax Inc. stock attractive after correctionQuarterly Investment Review & Weekly Watchlist of Top Performers - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Using Bollinger Bands to evaluate Novavax Inc.2025 Price Momentum & AI Enhanced Trading Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Will Novavax Inc. (NVV1) stock benefit from sector leadership2025 Trading Volume Trends & Free Safe Entry Trade Signal Reports - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is Novavax Inc. stock attractive for retirement portfoliosPortfolio Gains Summary & Daily Growth Stock Investment Tips - newser.com

Oct 03, 2025
pulisher
Oct 01, 2025

Novavax Inc. (NVAX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Oct 01, 2025
pulisher
Oct 01, 2025

Noteworthy Wednesday Option Activity: ONON, NVAX, COMM - Nasdaq

Oct 01, 2025
pulisher
Oct 01, 2025

Novavax’s Vaccine Milestone and Market Movement - StocksToTrade

Oct 01, 2025
pulisher
Oct 01, 2025

Will Novavax Inc. stock benefit from AI adoptionInsider Selling & Precise Buy Zone Tips - newser.com

Oct 01, 2025
pulisher
Oct 01, 2025

Will Novavax Inc. outperform the market2025 Valuation Update & Precise Buy Zone Identification - newser.com

Oct 01, 2025
pulisher
Oct 01, 2025

Novavax expands Sanofi partnership for pandemic flu vaccine development By Investing.com - Investing.com Nigeria

Oct 01, 2025
pulisher
Sep 30, 2025

Novavax (NVAX) Expands License for Matrix-M with Sanofi - GuruFocus

Sep 30, 2025
pulisher
Sep 30, 2025

Novavax (NVAX) Exceeds Market Returns: Some Facts to Consider - sharewise.com

Sep 30, 2025
pulisher
Sep 30, 2025

Novavax Deepens Partnership with Sanofi: Matrix-M Adjuvant Set to Bolster Pandemic Influenza Vaccine Development - BBN Times

Sep 30, 2025
pulisher
Sep 30, 2025

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - MSN

Sep 30, 2025
pulisher
Sep 30, 2025

Novavax Amends Deal With Sanofi, Broadens Partnership - Stocktwits

Sep 30, 2025
pulisher
Sep 30, 2025

Novavax allows Sanofi to use Matrix-M adjuvant for pandemic flu candidate - Seeking Alpha

Sep 30, 2025
pulisher
Sep 30, 2025

Novavax expands Sanofi partnership for pandemic flu vaccine development - Investing.com

Sep 30, 2025
pulisher
Sep 30, 2025

Novavax Announces Progress on Sanofi Agreement - PR Newswire

Sep 30, 2025
pulisher
Sep 30, 2025

Novavax falls after guidance cut on lower vaccine sales - MSN

Sep 30, 2025
pulisher
Sep 30, 2025

What analysts say about Novavax Inc NVV1 stockPrice Momentum Alerts & Breakout Stock Alerts - earlytimes.in

Sep 30, 2025
pulisher
Sep 30, 2025

Ask Axios: Where to find a Novavax shot in Ohio - Axios

Sep 30, 2025
pulisher
Sep 30, 2025

Can Novavax Inc. rally from current levels2025 Market Sentiment & AI Optimized Trade Strategies - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

What analysts say about Novavax Inc stockMarket Sentiment Indicators & Superior Growth Trading - earlytimes.in

Sep 29, 2025
pulisher
Sep 28, 2025

Novavax Inc Stock Analysis and ForecastMarket Sentiment Report & The Smart Money Is Buying These Picks - earlytimes.in

Sep 28, 2025
pulisher
Sep 26, 2025

Here's Why Novavax (NVAX) is a Strong Momentum Stock - sharewise.com

Sep 26, 2025
pulisher
Sep 26, 2025

Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough' - Benzinga

Sep 26, 2025
pulisher
Sep 25, 2025

Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock - sharewise.com

Sep 25, 2025
pulisher
Sep 25, 2025

Novavax, Inc. (NASDAQ:NVAX) Given Consensus Rating of "Hold" by Brokerages - MarketBeat

Sep 25, 2025
pulisher
Sep 25, 2025

Citi Initiates Coverage of Novavax (NVAX) With a Sell Rating - MSN

Sep 25, 2025

Novavax Inc Azioni (NVAX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$21.43
price up icon 2.68%
$86.85
price up icon 0.66%
$33.56
price up icon 4.48%
$105.49
price up icon 0.94%
$157.16
price up icon 2.85%
biotechnology ONC
$343.87
price down icon 0.38%
Capitalizzazione:     |  Volume (24 ore):